These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33783011)

  • 1. Fusion designs and estimators for treatment effects.
    Breskin A; Cole SR; Edwards JK; Brookmeyer R; Eron JJ; Adimora AA
    Stat Med; 2021 Jun; 40(13):3124-3137. PubMed ID: 33783011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and robust methods for causally interpretable meta-analysis: Transporting inferences from multiple randomized trials to a target population.
    Dahabreh IJ; Robertson SE; Petito LC; Hernán MA; Steingrimsson JA
    Biometrics; 2023 Jun; 79(2):1057-1072. PubMed ID: 35789478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusing trial data for treatment comparisons: Single vs multi-span bridging.
    Shook-Sa BE; Zivich PN; Rosin SP; Edwards JK; Adimora AA; Hudgens MG; Cole SR
    Stat Med; 2024 Feb; 43(4):793-815. PubMed ID: 38110289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving transportability of randomized controlled trial inference using robust prediction methods.
    Elliott MR; Carroll O; Grieve R; Carpenter J
    Stat Methods Med Res; 2023 Dec; 32(12):2365-2385. PubMed ID: 37936293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illustration of 2 Fusion Designs and Estimators.
    Cole SR; Edwards JK; Breskin A; Rosin S; Zivich PN; Shook-Sa BE; Hudgens MG
    Am J Epidemiol; 2023 Feb; 192(3):467-474. PubMed ID: 35388406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging prognostic baseline variables to gain precision in randomized trials.
    Colantuoni E; Rosenblum M
    Stat Med; 2015 Aug; 34(18):2602-17. PubMed ID: 25872751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias.
    Pressler TR; Kaizar EE
    Stat Med; 2013 Sep; 32(20):3552-68. PubMed ID: 23553373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.
    Antonelli J; Han B; Cefalu M
    Stat Med; 2017 Dec; 36(29):4604-4615. PubMed ID: 28833307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population.
    Dahabreh IJ; Haneuse SJA; Robins JM; Robertson SE; Buchanan AL; Stuart EA; Hernán MA
    Am J Epidemiol; 2021 Aug; 190(8):1632-1642. PubMed ID: 33324969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced precision in the analysis of randomized trials with ordinal outcomes.
    Díaz I; Colantuoni E; Rosenblum M
    Biometrics; 2016 Jun; 72(2):422-31. PubMed ID: 26576013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting participant noncompliance across multiple time points by modeling a longitudinal biomarker.
    Peterson RL; Koopmeiners JS; Smith TT; Murphy SE; Donny EC; Vock DM
    Clin Trials; 2021 Feb; 18(1):28-38. PubMed ID: 32921152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data Integration in Causal Inference.
    Shi X; Pan Z; Miao W
    Wiley Interdiscip Rev Comput Stat; 2023; 15(1):. PubMed ID: 36713955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weighted Kaplan-Meier estimators for two-stage treatment regimes.
    Miyahara S; Wahed AS
    Stat Med; 2010 Nov; 29(25):2581-91. PubMed ID: 20799259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.